Canada -
anglais -
Health Canada
lariam tab 250mg tablet
hoffmann-la roche limited - mefloquine (mefloquine hydrochloride) - tablet - 250mg - mefloquine (mefloquine hydrochloride) 250mg - antimalarials
Canada -
anglais -
Health Canada
mefloquine tablet
aa pharma inc - mefloquine (mefloquine hydrochloride) - tablet - 250mg - mefloquine (mefloquine hydrochloride) 250mg - antimalarials
Australie -
anglais -
Department of Health (Therapeutic Goods Administration)
intron a redipen
merck sharp & dohme australia pty ltd - interferon alfa-2b -
Australie -
anglais -
Department of Health (Therapeutic Goods Administration)
intron-a
interferon alfa-2b -
Nouvelle-Zélande -
anglais -
Medsafe (Medicines Safety Authority)
intron a redipen
merck sharp & dohme (new zealand) limited - interferon alfa-2b 15 miu/ml - solution for injection - 18 miu - active: interferon alfa-2b 15 miu/ml excipient: dibasic sodium phosphate disodium edetate dihydrate metacresol monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - intron a redipen is used in the treatment of: · hairy cell leukaemia in splenectomised or non-splenectomised patients; · chronic myelogenous leukaemia;
Nouvelle-Zélande -
anglais -
Medsafe (Medicines Safety Authority)
intron a redipen
merck sharp & dohme (new zealand) limited - interferon alfa-2b 25 miu/ml - solution for injection - 30 miu - active: interferon alfa-2b 25 miu/ml excipient: dibasic sodium phosphate disodium edetate dihydrate metacresol monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - intron a redipen is used in the treatment of: · hairy cell leukaemia in splenectomised or non-splenectomised patients; · chronic myelogenous leukaemia;
Nouvelle-Zélande -
anglais -
Medsafe (Medicines Safety Authority)
intron a redipen
merck sharp & dohme (new zealand) limited - interferon alfa-2b 50 miu/ml - solution for injection - 60 miu - active: interferon alfa-2b 50 miu/ml excipient: dibasic sodium phosphate disodium edetate dihydrate metacresol monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - intron a redipen is used in the treatment of: · hairy cell leukaemia in splenectomised or non-splenectomised patients; · chronic myelogenous leukaemia;
Nouvelle-Zélande -
anglais -
Medsafe (Medicines Safety Authority)
intron-a
merck sharp & dohme (new zealand) limited - interferon alfa-2b 10 miu/ml; - solution for injection - 10 miu/ml - active: interferon alfa-2b 10 miu/ml excipient: dibasic sodium phosphate disodium edetate dihydrate metacresol monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection